A multitude of midstream and downstream domestic Brain-Computer Interface (BCI) companies have been actively engaging with BCI industry matching platforms, seeking to establish connections with upstream suppliers in Shenzhen for essential raw materials like chips, packaging components, and wires. The roster of these enterprises is constantly expanding. This surge in activity is far from coincidental; in the current year, BCI has reignited fervor within the medical venture capital landscape. According to preliminary statistics, in the first five months of 2026 alone, China's BCI sector witnessed over 30 financing events, cumulatively raising more than 4.6 billion yuan. BCI, once perceived as a 'niche and cutting-edge domain,' has swiftly transformed into a burgeoning hotspot within a mere six-month span.
